Polyarteritis Nodosa-like Vasculitis in Association with Minocycline Use: A Single-Center Case Series

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 2, 2012, Pages 213-221

  Kermani, Tanaz A ^a,b   Ham, Erin K ^a   Camilleri, Michael J ^a   Warrington, Kenneth J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ADVERSE OUTCOME; ANTIBODY BLOOD LEVEL; ARTICLE; CHOLECYSTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ENZYME SPECIFICITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ANGIOGRAPHY; MALE; MICROANEURYSM; MONONEUROPATHY MULTIPLEX; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RENAL ARTERY ANEURYSM; SKIN BIOPSY; SKIN DISEASE; SYSTEMIC DISEASE; TREATMENT DURATION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MINOCYCLINE; POLYARTERITIS NODOSA; YOUNG ADULT;

EID: 84866483955     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.03.006     Document Type: Article

References (32)

1. Watts R.A., Lane S.E., Bentham G., Scott D.G. Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis Rheum 2000, 43(2):414-419.
2. Scott D.G., Watts R.A. Systemic vasculitis: Epidemiology, classification and environmental factors. Ann Rheum Dis 2000, 59(3):161-163.
3. McMahon B.J., Heyward W.L., Templin D.W., Clement D., Lanier A.P. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: Clinical and epidemiologic features and long-term follow-up. Hepatology 1989, 9(1):97-101.
4. Guillevin L., Mahr A., Callard P., Godmer P., Pagnoux C., Leray E., et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005, 84(5):313-322.
5. Pernice W., Sodomann C.P., Lüben G., Seiler F.R., Sedlacek H.H. Antigen-specific detection of HBsAg-containing immune complexes in the course of hepatitis B virus infection. Clin Exp Immunol 1979, 37(2):376-380.
6. Zuckerman A.J. Proceedings: Hepatitis B, immune complexes, and the pathogenesis of polyarteritis nodosa. J Clin Pathol 1976, 29(1):84-85.
7. Guillevin L., Ronco P., Verroust P. Circulating immune complexes in systemic necrotizing vasculitis of the polyarteritis nodosa group. Comparison of HBV-related polyarteritis nodosa and Churg Strauss angiitis. J Autoimmun 1990, 3(6):789-792.
8. Shapiro L.E., Knowles S.R., Shear N.H. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997, 133(10):1224-1230.
9. Merkel P.A. Drug-induced vasculitis. Rheum Dis Clin North Am 2001, 27(4):849-862.
10. Kircik L.H. Doxycycline and minocycline for the management of acne: A review of efficacy and safety with emphasis on clinical implications. J Drugs Dermatol 2010, 9(11):1407-1411.
11. Chang C., Gershwin M.E. Drugs and autoimmunity-A contemporary review and mechanistic approach. J Autoimmun 2010, 34(3):J266-J275.
12. Schrodt B.J., Kulp-Shorten C.L., Callen J.P. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 1999, 92(5):502-504.
13. Schaffer J.V., Davidson D.M., McNiff J.M., Bolognia J.L. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001, 44(2):198-206.
14. Sakai H., Komatsu S., Matsuo S., Iizuka H. [Two cases of minocycline-induced vasculitis]. Arerugi 2002, 51(12):1153-1158.
15. Pelletier F., Puzenat E., Blanc D., Faivre B., Humbert P., Aubin F. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 2003, 13(4):396-398.
16. Culver B., Itkin A., Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 2005, 53(3):468-470.
17. Abad S., Kambouchner M., Nejjari M., Dhote R. Additional case of minocycline-induced cutaneous polyarteritis nodosa: Comment on the article by Culver, et al. Arthritis Rheum 2006, 55(5):831. Author reply 832.
18. Katada Y., Harada Y., Azuma N., Matsumoto K., Terada H., Kudo E., et al. Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol 2006, 16(4):256-259.
19. Tehrani R., Nash-Goelitz A., Adams E., Dahiya M., Eilers D. Minocycline-induced cutaneous polyarteritis nodosa. J Clin Rheumatol 2007, 13(3):146-149.
20. Gait R.C., Affleck A.G., Leach I.H., Varma S. Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris. J Am Acad Dermatol 2008, 58(5 Suppl 1):S123-S124.
21. Ogawa N., Kawai H., Yamakawa I., Sanada M., Sugimoto T., Maeda K. [Case of minocycline-induced vasculitic neuropathy]. Rinsho Shinkeigaku 2010, 50(5):301-305.
22. Elkayam O., Yaron M., Caspi D. Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis 1996, 55(10):769-771.
23. Elkayam O., Levartovsky D., Brautbar C., Yaron M., Burke M., Vardinon N., et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998, 105(6):484-487.
24. Devaney K.O., Travis W.D., Hoffman G., Leavitt R., Lebovics R., Fauci A.S. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990, 14(6):555-564.
25. Hoffman G.S., Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998, 41(9):1521-1537.
26. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: Indications for the classification of vasculitides of the Polyarteritis Nodosa Group. Br J Rheumatol 1996, 35(10):958-964.
27. Marzo-Ortega H., Baxter K., Strauss R.M., Drysdale S., Griffiths B., Misbah S.A., et al. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity?. A cross-sectional study. Br J Dermatol 2007, 156(5):1005-1009.
28. Jiang X., Khursigara G., Rubin R.L. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994, 266(5186):810-813.
29. Dunphy J., Oliver M., Rands A.L., Lovell C.R., McHugh N.J. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 2000, 142(3):461-467.
30. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110(7):955-963.
31. Bansal P.J., Tobin M.C. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004, 93(4):398-401.
32. Silva F., Specks U., Sethi S., Irazabal M.V., Fervenza F.C. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis 2009, 54(3):542-545.